ASA Biopharm's Podcast

In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.

http://community.amstat.org/BioP/Home/

Eine durchschnittliche Folge dieses Podcasts dauert 35m. Bisher sind 63 Folge(n) erschienen.
subscribe
share



 

Episode 42: Committee on Minorities in Statistics


Reneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.


share





 2017-06-29  47m
 
 

Episode 41: Liz Stuart


Liz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.


share





 2017-06-05  42m
 
 

Episode 40: Estimands


Yuki Ando, Frank Bretz, Rob Hemmings and Tom Permutt discuss estimands and the ICH E9 revisions.


share





 2017-05-08  56m
 
 

Episode 39: Alex Dmitrienko


Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.


share





 2017-03-14  58m
 
 

Episode 39: Alex Dmitrienko


Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.


share





 2017-03-14  58m
 
 

Episode 38: Amanda Golbeck


Amanda discusses statistical leadership and her book Leadership and Women in Statistics.


share





 2017-02-20  33m
 
 

Episode 37: Multiregional Clinical Trials


Aloka Chakravarty, Laurie Letvak and Bill Wang discuss MRCTs and the draft ICH E17 guidance.


share





 2017-01-26  1h1m
 
 

Episode 36: Statistical Leadership


Sonia Davis, Bill Sollecito and Paula Brown Stafford discuss statistical leadership and leadership training at the University of North Carolina at Chapel Hill.


share





 2016-12-21  59m
 
 

Episode 35: EFSPI Benefit-Risk Working Group


Alexander Schacht and Ian Hirsch discuss benefit-risk and the efforts of the EFSPI working group.


share





 2016-11-10  44m
 
 

Episode 34: Patient Preferences in Medical Product Evaluation


Telba Irony and Martin Ho discuss the important of patient preferences.


share





 2016-10-07  45m